Yungjin Pharm. Co., Ltd. (KRX:003520)
2,080.00
+5.00 (0.24%)
Feb 19, 2025, 9:00 AM KST
Yungjin Pharm. Company Description
Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products.
The company also provides vitamins, minerals, and other products; and APIs. Yungjin Pharm.
Co., Ltd. was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm.
Co., Ltd. operates as a subsidiary of KT&G Corporation.
Yungjin Pharm. Co., Ltd.
Country | South Korea |
Founded | 1952 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 574 |
CEO | Chae-Joon Lee |
Contact Details
Address: Jamsil Company Building Seoul, 05510 South Korea | |
Phone | 82 2 2041 8200 |
Website | yungjin.co.kr |
Stock Details
Ticker Symbol | 003520 |
Exchange | Korea Stock Exchange |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | KRW |
ISIN Number | KR7003520004 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Chae-Joon Lee | Chief Executive Officer and President |